Education
About Us
Working with TipRanks
Follow Us
China Sanjiang Fine Chemicals Co., Ltd. (HK:2198)
:2198
RESEARCH TOOLSreports
Top Page
China Sanjiang Fine Chemicals Co., Ltd.
(2198)
54Neutral
China Sanjiang Fine Chemicals Co., Ltd. (2198) vs. S&P 500 (SPY)
Market Cap
HK$2.10B
Dividend YieldN/A
Average Volume (3M)402.00K
Price to Earnings (P/E)3.5
Beta (1Y)0.49
Revenue Growth47.32%
EPS Growth492.76%
CountryHK
Employees1,430
SectorBasic Materials
Sector Strength60
IndustryChemicals
Share Statistics
EPS (TTM)0.51
Shares Outstanding1,190,000,000
10 Day Avg. Volume188,000
30 Day Avg. Volume402,000
Financial Highlights & Ratios
PEG Ratio0.06
Price to Book (P/B)0.44
Price to Sales (P/S)0.00
P/FCF Ratio-2.54
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
China Sanjiang Fine Chemicals Co., Ltd. Business Overview & Revenue Model
Company DescriptionChina Sanjiang Fine Chemicals Co., Ltd. (2198) is a prominent Chinese chemical manufacturing company primarily engaged in the production and sale of ethylene oxide and other ethylene derivatives. The company operates in the petrochemical sector, focusing on the manufacture of fine chemical products that are essential for various industrial applications. Its core products serve industries such as textiles, detergents, and pharmaceuticals, highlighting its integral role in the supply chain of essential chemicals.
How the Company Makes MoneyChina Sanjiang Fine Chemicals Co., Ltd. generates revenue through the production and sale of chemical products, with a primary focus on ethylene oxide, a key raw material for various industrial processes. The company's revenue streams include direct sales to manufacturers in industries such as textiles, detergents, and pharmaceuticals that require ethylene derivatives for their production processes. Additionally, the company benefits from long-term supply agreements and strategic partnerships with industry players, ensuring a stable demand for its products. The efficient production processes and strategic geographic location also contribute to the company's profitability by optimizing costs and ensuring timely delivery to its customers.
China Sanjiang Fine Chemicals Co., Ltd. Financial Statement Overview
Summary
Income Statement
Balance Sheet
Cash Flow
| Breakdown | |||||
| TTM | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|---|
| Income Statement | Total Revenue | ||||
| 17.78B | 13.13B | 8.82B | 9.50B | 8.32B | 9.19B | Gross Profit |
| 636.55M | 168.77M | -70.38M | 634.52M | 1.63B | 1.06B | EBIT |
| 404.76M | -35.48M | -811.83M | -104.88M | 1.07B | 709.35M | EBITDA |
| 1.64B | 812.91M | 349.18M | 388.69M | 1.64B | 1.30B | Net Income Common Stockholders |
| 219.41M | 91.48M | -307.88M | 380.61M | 1.12B | 550.47M |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
| 991.65M | 625.40M | 387.63M | 807.28M | 946.58M | 1.15B | Total Assets |
| 9.38B | 21.00B | 18.26B | 14.28B | 11.02B | 10.41B | Total Debt |
| 3.06B | 10.27B | 10.52B | 6.27B | 4.21B | 4.11B | Net Debt |
| 2.61B | 9.91B | 10.30B | 5.68B | 3.44B | 3.52B | Total Liabilities |
| 5.79B | 16.64B | 13.93B | 9.54B | 6.23B | 6.36B | Stockholders Equity |
| 3.60B | 4.38B | 4.30B | 4.67B | 4.71B | 4.04B |
| Cash Flow | Free Cash Flow | ||||
| -785.25M | -1.29B | -3.52B | -834.29M | -209.13M | 1.03B | Operating Cash Flow |
| 378.55M | -122.01M | -910.52M | 1.63B | 1.74B | 1.24B | Investing Cash Flow |
| -893.88M | -790.28M | -1.97B | -3.29B | -1.07B | -2.22B | Financing Cash Flow |
| 509.47M | 1.06B | 2.50B | 1.48B | -485.13M | 1.12B |
China Sanjiang Fine Chemicals Co., Ltd. Technical Analysis
Positive
1.78
Price Trends
1.76
Positive
1.76
Positive
1.72
Positive
Market Momentum
0.02
Negative
53.50
Neutral
50.00
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2198, the sentiment is Positive. The current price of 1.78 is above the 20-day moving average (MA) of 1.73, above the 50-day MA of 1.76, and above the 200-day MA of 1.72, indicating a bullish trend. The MACD of 0.02 indicates Negative momentum. The RSI at 53.50 is Neutral, neither overbought nor oversold. The STOCH value of 50.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:2198.
China Sanjiang Fine Chemicals Co., Ltd. Peers Comparison
Overall Rating
UnderperformOutperform
Sector (50)
Financial Indicators
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | $63.59B | 13.83 | 13.20% | 5.99% | -9.60% | -27.18% | |
75 Outperform | $1.02T | 3.96 | 22.83% | 4.30% | 5.96% | 124.20% | |
68 Neutral | $119.71B | 5.75 | 22.05% | 17.24% | 2.87% | ― | |
62 Neutral | HK$31.40B | 8.56 | 5.72% | 3.81% | 74.12% | 11.54% | |
54 Neutral | HK$2.10B | 3.51 | 11.49% | ― | 47.32% | 492.76% | |
50 Neutral | $1.97B | -1.14 | -21.33% | 3.61% | 1.59% | -30.68% | |
40 Underperform | $2.37B | ― | -90.47% | ― | -1.96% | -17.34% |
* Basic Materials Sector Average
Performance Comparison
HK:2198
China Sanjiang Fine Chemicals Co., Ltd.
1.78
0.03
1.71%
HK:1171
Yankuang Energy Group Company Limited Class H
8.75
-4.03
-31.56%
HK:2628
China Life Insurance Co
15.96
3.67
29.88%
HK:3383
Agile Group Holdings
0.47
-0.46
-49.46%
HK:2866
COSCO SHIPPING Development Co
1.09
0.11
11.22%
HK:1093
CSPC Pharmaceutical Group
5.71
-0.60
-9.55%
China Sanjiang Fine Chemicals Co., Ltd. Corporate Events
China Sanjiang Fine Chemicals Announces 2025 Annual General Meeting
Apr 29, 2025
China Sanjiang Fine Chemicals Co., Ltd. has announced its upcoming annual general meeting scheduled for May 30, 2025, in Hong Kong. The meeting will address several key business items, including the approval of financial statements, re-election of directors, and re-appointment of auditors. Additionally, the company seeks shareholder approval to authorize directors to issue new shares, potentially impacting the company’s capital structure and market positioning.
China Sanjiang Fine Chemicals Terminates Management Agreement Amid Tariff Concerns
Apr 9, 2025
China Sanjiang Fine Chemicals Co., Ltd. has announced the termination of its Management Agreement with Grand Novel due to logistical uncertainties stemming from recent tariffs imposed by the USA and counter-tariffs by China. The company believes this decision is in the best interest of its shareholders and will consider new management agreements if necessary.
China Sanjiang Fine Chemicals Reports Robust 2024 Financial Results Amid Sector Challenges
Mar 28, 2025
China Sanjiang Fine Chemicals Co., Ltd. reported a significant increase in its annual results for 2024, with revenue rising by 49.2% and net profit surging by 482.2%. This growth was driven by improved selling prices and sales volumes of key products like ethylene glycol and butadiene, amidst a challenging year for the oil and chemical sector in China. The company’s strategic expansion and operational ramp-up have positioned it well for recovery and growth, despite global geopolitical challenges and commodity price volatility.
China Sanjiang Fine Chemicals to Announce 2024 Financial Results and Dividend Decision
Mar 12, 2025
China Sanjiang Fine Chemicals Co., Ltd. has announced that its board of directors will meet on March 28, 2025, to approve the company’s final results for the year ending December 31, 2024, and to consider the payment of a final dividend. This meeting is significant for stakeholders as it will determine the company’s financial performance and potential dividend distribution, impacting investor confidence and market positioning.
Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.